Arca Biopharma Stock Target Price and Analyst Consensus

ABIO
 Stock
  

USD 2.08  0.03  1.46%   

The current analyst and expert consensus on Arca Biopharma is Strong Buy, with 1 strong buy opinions. The current projected Arca Biopharma target price consensus is 16.5 with 1 analyst opinions. The most common way Arca Biopharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Arca Biopharma executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Arca Biopharma. We encourage you to use your own analysis of Arca Biopharma to validate this buy or sell advice. Arca Biopharma buy-or-sell recommendation module provides average expert sentiment on the projected Arca Biopharma target price to derive its highest and lowest estimates based on its projected price volatility. Please continue to Macroaxis Advice on Arca Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Arca Biopharma Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arca Biopharma target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Arca Biopharma target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of OpinionsOne
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Arca Biopharma analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Arca Biopharma stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Arca Biopharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Arca Biopharma Target Price Projection

Arca Biopharma's current and average target prices are 2.08 and 16.50, respectively. The current price of Arca Biopharma is the price at which Arca Biopharma is currently trading. On the other hand, Arca Biopharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Arca Biopharma Market Quote on 29th of November 2022

Low Price2.04Odds
High Price2.12Odds

2.08

Target Price

Analyst Consensus On Arca Biopharma Target Price

Low Estimate16.5Odds
High Estimate16.5Odds
Number of AnalystsOne
Standard Deviation0.0

16.5

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Arca Biopharma and the information provided on this page.

Arca Biopharma Analyst Ratings

Arca Biopharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Arca Biopharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Arca Biopharma's financials, market performance, and future outlook by experienced professionals. Arca Biopharma's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Arca Biopharma Target Price Projections

Arca Biopharma's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Arca Biopharma and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Arca Biopharma depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Arca Biopharma including analysis of its current option contracts.
Arca Biopharma's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 81.95 with a put-to-call open interest ratio of 0.99 over 6 outstanding agreements suggesting . The current put volume is at 95, with calls trading at the volume of 170. This yields a 0.56 put-to-call volume ratio. The Arca Biopharma option chain provides detailed quote and price information for the current Arca Biopharma option contracts. It shows all of Arca Biopharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Arca Biopharma's stock options are financial instruments that give investors the right to buy or sell shares of Arca Biopharma common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Arca Biopharma stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Arca Biopharma's stock price goes up or down, the stock options follow.
Please continue to Macroaxis Advice on Arca Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Arca Biopharma Current Options Market Mood

Arca Biopharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arca Biopharma Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Arca Biopharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Arca Biopharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Arca Biopharma's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Arca Biopharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arca Biopharma is a key component of Arca Biopharma valuation and have some predictive power on the future returns of a Arca Biopharma.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Arca Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Arca Biopharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.102.054.29
Details
Intrinsic
Valuation
LowReal ValueHigh
1.855.677.91
Details
Naive
Forecast
LowNext ValueHigh
0.0432442.164.40
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.952.052.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arca Biopharma. Your research has to be compared to or analyzed against Arca Biopharma's peers to derive any actionable benefits. When done correctly, Arca Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Arca Biopharma.

Additional Arca Biopharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arca Biopharma is a key component of Arca Biopharma valuation and have some predictive power on the future returns of a Arca Biopharma.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Arca Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Arca Biopharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.102.054.29
Details
Intrinsic
Valuation
LowReal ValueHigh
1.855.677.91
Details
Naive
Forecast
LowNext ValueHigh
0.0432442.164.40
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.952.052.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arca Biopharma. Your research has to be compared to or analyzed against Arca Biopharma's peers to derive any actionable benefits. When done correctly, Arca Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Arca Biopharma.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Diversified Assets
Invested over 90 shares
Macroaxis Index
Invested over 90 shares
Baby Boomer Prospects
Invested over 90 shares
Please continue to Macroaxis Advice on Arca Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for analysis

When running Arca Biopharma price analysis, check to measure Arca Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arca Biopharma is operating at the current time. Most of Arca Biopharma's value examination focuses on studying past and present price action to predict the probability of Arca Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arca Biopharma's price. Additionally, you may evaluate how the addition of Arca Biopharma to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
The data published in Arca Biopharma's official financial statements usually reflect Arca Biopharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Arca Biopharma. For example, before you start analyzing numbers published by Arca Biopharma accountants, it's critical to develop an understanding of what Arca Biopharma's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Arca Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arca Biopharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Arca Biopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Arca Biopharma. Please utilize our Beneish M Score to check the likelihood of Arca Biopharma's management to manipulate its earnings.